Form 4: Alignment Healthcare CMO Granted 52,972 RSUs

Alignment Healthcare's Chief Medical Officer, Hyong Kim, was granted 52,972 restricted stock units, aligning executive incentives with long-term company performance.

Summary

• Hyong Kim, Chief Medical Officer of Alignment Healthcare, Inc. (ALHC), acquired 52,972 restricted stock units (RSUs).
• The transaction date for this acquisition was March 13, 2026.
• Each restricted stock unit represents the right to receive one share of Common Stock of the Company.
• The RSUs will vest approximately one-third on each of the first three anniversaries of the grant date.
• Vesting is contingent upon the reporting person's continued service to the Company as of the applicable vesting date.
• Following this transaction, Hyong Kim beneficially owns 386,105 shares of Common Stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting executive retention and alignment of interests, which are generally favorable for long-term company stability and performance.

Positives

• The grant of restricted stock units aligns the Chief Medical Officer's interests with long-term shareholder value.
• The three-year vesting schedule encourages executive retention and commitment to the company's future performance.
• The transaction was made under a Rule 10b5-1 plan, indicating a pre-planned, non-discretionary acquisition, which enhances transparency.

Negatives

• The future issuance of shares upon vesting could lead to minor dilution for existing shareholders, which is a standard aspect of equity compensation plans.

Risks

• The reporting person must maintain continued service to Alignment Healthcare for the restricted stock units to vest according to the schedule.

Future Outlook

The grant of restricted stock units with a multi-year vesting schedule indicates the company's strategy to retain key executives and align their long-term incentives with the company's future performance and growth objectives.

Industry Context

StockSavvy.ai notes that equity grants, particularly restricted stock units with time-based vesting, are a standard practice in the healthcare industry to incentivize and retain senior leadership. This grant to a Chief Medical Officer is consistent with typical executive compensation structures aimed at fostering long-term commitment and aligning management interests with shareholder returns.

Comparison to Industry Standards

• The grant of restricted stock units to a Chief Medical Officer is a common executive compensation tool across the healthcare sector, similar to practices at companies like UnitedHealth Group, Elevance Health, or Humana, which frequently use equity awards to retain top talent.
• The three-year vesting schedule, with approximately one-third vesting annually, is a standard industry practice designed to ensure long-term executive commitment and is comparable to vesting schedules seen in many S&P 500 companies' equity compensation plans.
• The 'zero price' for the acquisition of RSUs is typical for compensation grants, reflecting that these are awarded as part of an executive's total compensation package rather than purchased at market value.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for minor dilution upon vesting, but also increased alignment of executive interests with long-term shareholder value.
• Employees: Reinforces the company's commitment to executive retention and incentivization through equity compensation.

Next Steps

• The restricted stock units will vest approximately one-third on March 13, 2027, March 13, 2028, and March 13, 2029, subject to continued service.

Key Dates

Keywords

Alignment Healthcare, ALHC, Hyong Kim, Chief Medical Officer, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Form 4, Equity Grant, 10b5-1 Plan